Christopher B. Ford
Seres Therapeutics (United States)
ORCID: 0000-0002-4079-8673Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial”.
Liu Gao, Petr Stastka, Michael C. Cheney, Jasmin Mahabamunuge, Mariam Torres Soto +5 more
Darren Abbey, Luca Issi, Candace Guiducci, Diego A Martinez, Toni Marie Delorey +10 more
Author response: The evolution of drug resistance in clinical isolates of Candida albicans
Darren Abbey, Luca Issi, Candace Guiducci, Diego A Martinez, Toni Marie Delorey +10 more
Christopher A. Desjardins, Paul A. Giardina, Kankana Bardhan, Swarna Pandian, Keith Halley +14 more